Viral hepatitis in African Americans

被引：1
|
作者：
Reid A.E. [1 ]
机构：
[1] GI Unit GJ724, Massachusetts General Hospital, Boston, MA 02114
来源：
Current Hepatitis Reports | 2008年 / 7卷 / 3期
关键词：
Racial Disparity; Noninjection Drug User;
D O I：
10.1007/s11901-008-0025-z
中图分类号：
学科分类号：
摘要：
Chronic liver disease is the 12th leading cause of death in the United States and a significant cause of productivity loss and morbidity. Viral hepatitis is an important public health concern with a disproportionate impact on the African American community. As a result, African Americans have the greatest incidence of hepatocellular carcinoma, the most devastating consequence of chronic liver disease. Data suggest that African Americans are less likely than other ethnic/racial groups to receive vaccinations for hepatitis A and hepatitis B, to receive antiviral therapy for chronic hepatitis B and hepatitis C, and to respond to antiviral treatment for hepatitis C. This report reviews the current literature regarding acute and chronic viral infections among African Americans and makes recommendations for future public health and research initiatives to improve outcomes in this population. Copyright © 2008 by Current Medicine Group LLC.
引用
收藏
页码：120 / 126
页数：6
相关论文
共 50 条
  • [1] Viral hepatitis and hepatocellular carcinoma in African Americans
    Reddy, SI
    Ukomadu, C
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (03) : 248S - 251S
  • [2] Hepatitis C in African Americans
    Pyrsopoulos, Nikolaos
    Jeffers, Lennox
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (02) : 185 - 193
  • [3] Hepatitis C in African Americans
    Whitt K.N.
    Fleckenstein J.F.
    [J]. Current Hepatitis Reports, 2008, 7 (4) : 139 - 144
  • [4] Hepatitis C in African Americans
    Saab, Sammy
    Jackson, Christian
    Nieto, Jose
    Francois, Fritz
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (10): : 1576 - 1584
  • [5] Treating hepatitis C in African Americans
    Jeffers, Lennox J.
    [J]. LIVER INTERNATIONAL, 2007, 27 (03) : 313 - 322
  • [6] African Americans have a lower viral clearance rate with combination interferon and ribavirin therapy for Hepatitis C
    Hepburn, MJ
    Cantu, NS
    Hepburn, LM
    Kadakia, SC
    Lawitz, EJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1162 - 1162
  • [7] Hepatitis c in African Americans: Summary of a workshop
    Howell, C
    Jeffers, L
    Hoofnagle, JH
    [J]. GASTROENTEROLOGY, 2000, 119 (05) : 1385 - +
  • [8] Hepatitis C virus infection in African Americans
    Pearlman, BL
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (01) : 82 - 91
  • [9] Fibrosis Progression in African Americans and Caucasian Americans With Chronic Hepatitis C
    Terrault, Norah A.
    Im, Kelly
    Boylan, Ross
    Bacchetti, Peter
    Kleiner, David E.
    Fontana, Robert J.
    Hoofnagle, Jay H.
    Belle, Steven H.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (12) : 1403 - 1411
  • [10] Pan-viral response in African Americans and European Americans with hepatocellular carcinoma
    Ewa, Theressa
    Do, Whitney L.
    Wang, Limin
    Forgues, Marshonna
    Wang, Xin W.
    [J]. CANCER RESEARCH, 2023, 83 (07)
12345